FDA Inspection 1209671 — Alvotech Swiss AG
The FDA completed an inspection of Alvotech Swiss AG on June 22, 2023 in Zurich. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- June 22, 2023
- Fiscal Year
- 2023
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Zurich (Switzerland)
Additional Details
Sponsor, Contract Research Organization